Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
04:10pm, Tuesday, 19'th May 2026
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is schedule
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
07:20pm, Wednesday, 13'th May 2026
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
04:31pm, Saturday, 09'th May 2026
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
07:31pm, Wednesday, 06'th May 2026
RxSight, Inc. (RXST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.03 per share a year ago.
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
04:05pm, Wednesday, 06'th May 2026
ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.
RxSight, Inc. to Present at the Bank of America Healthcare Conference
04:10pm, Wednesday, 29'th Apr 2026
ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participat
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
04:10pm, Wednesday, 22'nd Apr 2026
ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesda
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
04:05pm, Wednesday, 08'th Apr 2026
WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that ove
RxSight (NASDAQ:RXST) Trading Down 3.7% – Time to Sell?
02:39am, Wednesday, 08'th Apr 2026
Shares of RxSight, Inc. (NASDAQ: RXST - Get Free Report) fell 3.7% on Tuesday. The company traded as low as $6.75 and last traded at $6.76. 430,271 shares were traded during trading, a decline of 45%
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
04:10pm, Thursday, 02'nd Apr 2026
ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Managemen
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Reduce” by Analysts
02:24am, Tuesday, 17'th Mar 2026
RxSight, Inc. (NASDAQ: RXST - Get Free Report) has received a consensus recommendation of "Reduce" from the fifteen analysts that are covering the stock, Marketbeat reports. Three equities research an
Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3%
01:03am, Tuesday, 03'rd Mar 2026
RxSight, Inc. (NASDAQ: RXST - Get Free Report) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 5,358,739 shares, an increase of
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
11:17pm, Wednesday, 25'th Feb 2026
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago.
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
11:00am, Wednesday, 18'th Feb 2026
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
